Hepatitis: all 3,372 studies
Page 32 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00351403Phase 4
- BreathID Multi-center HCV Liver Breath Test StudyTerminatedNCT00350714Phase 2
- Screening for Hepatitis C During Pregnancy at a Toronto Inner City Prenatal ClinicCompletedNCT00348660
- Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis CCompletedNCT00343525Phase 1
- Association Between Hepatitis C Virus Infection and Hematologic and Thyroid CancersCompletedNCT00342641
- Genes Involved in Resistance or Susceptibility to Hepatitis B VirusCompletedNCT00342186
- Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/HibCompletedNCT00335881Phase 4
- A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis CStatus unknownNCT00332176Phase 2
- A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)CompletedNCT00328549Phase 2
- Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood LymphocytesCompletedNCT00324389Phase 2
- Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.CompletedNCT00323804Phase 2/3
- Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)CompletedNCT00322361Phase 2
- Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis CCompletedNCT00322179
- Evaluation and Medico-Economic Study of FIBROSCAN in Patients With Viral HepatitisTerminatedNCT00318682
- Trial of Citalopram for the Prevention of DepressionCompletedNCT00317746Phase 3
- Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.CompletedNCT00317187Phase 3
- Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.CompletedNCT00317161Phase 3
- Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.CompletedNCT00317135Phase 3
- Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at BirthCompletedNCT00317122Phase 3
- Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.TerminatedNCT00316680Phase 3
- Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination SchedulesCompletedNCT00316147Phase 3
- NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus CoinfectionCompletedNCT00315432Phase 2
- Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy AdultsCompletedNCT00314054Phase 1
- Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
- Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBVTerminatedNCT00313287Phase 3
- Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBVTerminatedNCT00313274Phase 3
- Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo GroupTerminatedNCT00313261Phase 2
- Chronic Hepatitis C Non-Responder Study With AdoMet and BetaineCompletedNCT00310336Phase 2/3
- 14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological ResponseCompletedNCT00308048Phase 3
- Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis BCompletedNCT00307242Phase 4
- Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis CTerminatedNCT00305383Phase 2
- Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B VirusTerminatedNCT00305019Phase 2
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)CompletedNCT00304551Phase 3
- Manhattan HIV/Hepatology Brain BankCompletedNCT00300209
- Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve SubjectsCompletedNCT00299936Phase 3
- Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis CCompletedNCT00298714Phase 4
- Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral MedicationTerminatedNCT00296972Phase 3
- Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant PatientsCompletedNCT00295607Phase 2
- An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00292084Phase 2
- A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.CompletedNCT00291980Phase 3
- Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B VaccinationCompletedNCT00291954Phase 3
- A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.CompletedNCT00291941Phase 3
- Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis BCompletedNCT00291616Phase 4
- Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy InfantsCompletedNCT00290303Phase 3
- Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib VaccineCompletedNCT00289796Phase 2
- Autoimmune Hepatitis StudyTerminatedNCT00286663
- MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C PositiveTerminatedNCT00284921Phase 3
- The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic EncephalopathyStatus unknownNCT00281502Phase 2
- Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)TerminatedNCT00279565Phase 4
- Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4CompletedNCT00277862Phase 4
- Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype ITerminatedNCT00277758Phase 1
- Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B InfectionCompletedNCT00277576Phase 1
- CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsCompletedNCT00277238Phase 2
- Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis BCompletedNCT00275938Phase 2/3
- A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.CompletedNCT00275652Phase 3
- Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis CCompletedNCT00275548Phase 4
- Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty LiverTerminatedNCT00274495Phase 4
- Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior TherapyCompletedNCT00266318Phase 4
- Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.CompletedNCT00263614
- Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis CCompletedNCT00262483Phase 2
- Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis CCompletedNCT00262379Phase 3
- Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis CCompletedNCT00252642Not applicable
- VX-950 and Peginterferon for Hepatitis CCompletedNCT00251199Phase 1
- A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian SubjectsCompletedNCT00249860Phase 3
- Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1CompletedNCT00249574Not applicable
- Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus InfectionCompletedNCT00248339Phase 3
- Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCVCompletedNCT00247884
- A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis CCompletedNCT00246363Phase 1/2
- Trial of Pegasys® in Patients With Chronic Hepatitis CCompletedNCT00245414Phase 4
- A Video-Based HCV Curriculum for Active Injection Drug UsersCompletedNCT00241943Not applicable
- A Video-Based HCV Curriculum for Drug UsersCompletedNCT00241917Not applicable
- Timing and Duration of Acute Hepatitis C TreatmentCompletedNCT00241618Phase 4
- Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis CCompletedNCT00239252Phase 3
- Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean PopulationCompletedNCT00237991
- Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)CompletedNCT00237484Phase 3
- Study of the Immune Response to Hepatitis C VirusCompletedNCT00237432
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-NaiveCompletedNCT00230958Phase 3
- Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and RibavirinCompletedNCT00230854Phase 1
- Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis BCompletedNCT00230503Phase 2
- Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201TerminatedNCT00230490Phase 2
- Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALTCompletedNCT00230477Phase 4
- Hepatitis B Vaccination in HIV-infected PersonsCompletedNCT00230061Phase 4
- Health Behavior Feedback Study for Veterans With Hepatitis CCompletedNCT00229580Phase 1
- HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B InfectionTerminatedNCT00228592Phase 2
- Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis CCompletedNCT00227435Phase 1/2
- Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis CCompletedNCT00227149
- Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B PatientsCompletedNCT00226447Phase 2
- Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral TreatmentCompletedNCT00226382Phase 4
- 4-Methylumbelliferone as a Treatment for Chronic HBV/HCVStatus unknownNCT00225537Phase 2
- The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic FailureCompletedNCT00224705Phase 3
- Qidong Hepatitis B Intervention StudyCompletedNCT00222664Phase 4
- Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected PatientsCompletedNCT00221624Phase 3
- Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected PatientsTerminatedNCT00221286Phase 3
- Hepatitis C Virus and the Humoral Immune SystemCompletedNCT00219999
- Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-ContaminationCompletedNCT00219453Phase 1
- Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1CompletedNCT00218556Not applicable
- A Trial to Reduce Hepatitis C Among Injection Drug Users - 1CompletedNCT00218192Phase 3
- A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00217139Phase 2
- Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis CCompletedNCT00216775
- PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With InterferonCompletedNCT00215891Phase 3